ScholarWorks@SUNGKYUNKWAN UNIVERSITY: LEE, NAM YONG

Detailed Information

LEE, NAM YONG (이남용)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Nontuberculous mycobacteria:21||Bacteremia:19||Mycobacterium abscessus:16||Mycobacterium avium complex:14||Performance:12||Drug resistance:10||Korea:9||nontuberculous mycobacteria:9||Realtime PCR:7||Mycobacterium tuberculosis:7||Treatment outcome:7||Escherichia coli:6||Mycobacterium massiliense:6||atypical mycobacteria:6||Cancer:5||Klebsiella pneumoniae:5||Resistance:5||treatment outcome:5||Sequencing:5||Staphylococcus aureus:4||Mycobacterium intracellulare:4||Validation:4||Pulmonary tuberculosis:4||Enterococcus:4||Streptococcus pneumoniae:4||Mycobacterium avium:4||bacteremia:4||risk factors:4||Pseudomonas aeruginosa:3||Clarithromycin:3||ESBL:3||Multiplex realtime PCR:3||Linezolid:3||Epidemiology:3||lung disease:3||macrolides:3||mortality:3||Vancomycinresistant enterococci:3||Bronchiectasis:3||Mycobacterium kansasii:3||amikacin:3||Macrolides:3||rifampin:3||Respiratory virus:3||Methicillinresistant Staphylococcus aureus:3||Identification:3||Cephalosporin resistance:3||Risk factors:3||SARSCoV2:3||16S rRNA:3||Genotype:3||Genotyping:3||Nontuberculous:3||drug resistance:3||Treatment:2||Mycobacterium infections:2||Levofloxacin:2||Quinolone:2||Infective endocarditis:2||Clostridium difficile:2||susceptibility:2||Culture media:2||Amikacin:2||antimicrobial resistance:2||Culture:2||Stenotrophomonas maltophilia:2||Acinetobacter baumannii:2||pulmonary coin lesion:2||pulmonary tuberculosis:2||PCR:2||Human papillomavirus:2||Influenza:2||Creactive protein:2||Republic of Korea:2||Comparison:2||resistance:2||Meningitis:2||Sequence analysis:2||COVID19:2||treatment:2||Minimum inhibitory concentration:2||16S ribosomal RNA:2||Drug susceptibility test:2||STANDARD F:2||Nontuberculous Mycobacteria:2||clofazimine:2||Isolation:2||Nontuberculous mycobacteria:2||ethambutol:2||VITEK 2:2||DNA test:2||Candida parapsilosis:2||Communityacquired infections:2||Bacteraemia:2||moxifloxacin:2||Predictor:2||Pneumonia:2||Liver abscess:2||Vancomycin resistance:2||communityacquired infections:2||inhalation:2||surgery:2||MALDITOF:2||Bloodstream infection:2||Extendedspectrum betalactamase:2||Diagnosis:2||DNA:2||Fluoroquinolones:1||Fungemia:1||GenoType NTMDR:1||Gentamicin:1||Geosmithia argillacea:1||Glutamate dehydrogenase:1||Gonococcal meningitis:1||GramNegative Bacilli:1||Guidelines:1||HBV:1||HHV6:1||Haemophilus influenzae:1||Head and neck abscess:1||Healthcareassociated:1||Healthcareassociated infection:1||Hearing loss:1||Helicobacter pylori:1||Hematologic malignancies:1||Hematologic malignancy:1||Hematopoietic stem cells:1||Hemolytic uremic syndrome:1||Herpesviridae:1||Heteroresistance:1||Hospitalacquired:1||Hospitalacquired pneumonia:1||Huaiyangshan banyangvirus:1||HybREAD480:1||Hydrogen peroxide:1||Hyperoxia:1||In vitro:1||Inappropriate:1||Infective Endocarditis:1||Influenza A&B Multiplex RealTime PCR Kit:1||Inoculum effect:1||Inspiratory oxygen fraction:1||Interferon γ release assay:1||Isoniazid:1||Isoniazid resistance:1||Klebsiella:1||Klebsiella aerogenes:1||Kocuria marina:1||Late drainage:1||Leptotrichia:1||Liquid media:1||Liquid medium:1||Liver cirrhosis:1||Liver transplantation:1||Loopmediated isothermal amplification assay:1||Lung disease:1||Lymphadenitis:1||Lymphoma:1||M. tuberculosis:1||MALDITOF MS:1||MALDITOF mass spectrometry:1||MERSCoV:1||MGIT 960 system:1||MIC:1||Macrolide:1||Melioidosis:1||Methicillin Resistance:1||Meticillinresistan:1||Meticillinresistant:1||MicroIDSys Elite:1||MicroScan Synergies plus Positive Combo 3 Panels:1||Microbacterium:1||Microbial:1||Microbial contamination:1||Microbial culture:1||Microbial drug resistance:1||Microbial sensitivity test:1||Microbial sensitivity tests:1||Minimum bactericidal concentration:1||MolecuTech REBA MycoID:1||Moxifloxacin:1||Mucorales:1||Mucormycosis:1||Multidrug resistance:1||Multidrugresistant tuberculosis:1||Multigene sequencing:1||Multilocus sequence typing:1||Multiplex PCR:1||MultiplexPCR:1||Mutation:1||Mutations:1||Myco:1||Mycobacterial Growth Indicator Tube:1||Mycobacterial culture:1||Mycobacterium:1||Mycobacterium Infections:1||Mycobacterium abscessus complex:1||Mycobacterium avium Complex:1||Mycobacterium avium c:1||Mycobacterium bovis:1||Mycobacterium celatum:1||Mycobacterium chimaera:1||Mycobacterium fortuitum:1||Mycobacterium fortuitum complex:1||Mycobacterium marseillense:1||Mycobacterium shimoidei:1||Mycobacterium tuberculosis complex:1||Mycobacterium xenopi:1||Mycobacteriurn kansasii:1||Mycological typing:1||Mycoplasma hominis:1||NME5:1||NTM:1||Nasal colonization:1||Nasopharynx:1||Natural history:1||Neisseria gonorrhoeae:1||Nested PCR:1||Nextgeneration sequencing:1||Nonalbicans candidemia:1||Nonneutropenia:1||Nonsusceptible:1||Normally sterile body fluid:1||Nosocomial infections:1||Ochrobactrum anthropi:1||Ofloxacin:1||Oxygen:1||PK/PD:1||Panels:1||Parvimonas micra:1||Pediatric Intensive Care Units:1||Pediatric bacteremia:1||Penicillin:1||Penicillium marneffei:1||Peritoneal dialysis:1||Peritonitis:1||Phaeohyphomycosis:1||PiperacillinTazobactam:1||Piperacillin/tazobactam:1||Pneumocystis jirovecii:1||Pneumocystis pneumonia:1||Polymerase chain reaction:1||Poor prognosis:1||Postoperative complication:1||PowerChek:1||PowerChek SARSCoV2:1||PowerChek SFTSV Realtime PCR kit:1||Prevalence:1||Primary ciliary dyskinesia:1||Primary liquid culture:1||Prosthetic joint infection:1||Proteus mirabilis:1||Prototheca bovis:1||Prototheca zopfii:1||Quality assurance:1||Quantification:1||RNA extraction:1||RSV:1||Raoultella ornithinolytica:1||Rasam:1||Realtime reverse transcription PCR:1||Realtime reversetranscription PCR:1||RealStar Pneumocystis jirovecii PCR:1||RealStar assay:1||Respiratory infection:1||Respiratory tract infections:1||Restriction fragment length polymorphism:1||Rifabutin:1||Rifampin:1||Risk factor:1||SD BIOLINE:1||SFTS virus:1||SFTSQS kit:1||SMG assay:1||ST7363:1||STEC:1||Salmonella:1||Semiquantitative result:1||Sepsis:1||Septic arthritis:1||Sequence Analysis:1||Sodium hypochlorite:1||Soft tissue infectio:1||Somatic variant:1||South Korea:1||Specimen collection:1||Sputum:1||Sputum microbiology:1||Stool antigen test:1||Streptococcus pyogenes:1||Streptococcus suis:1||Stx loss:1||Susceptibility:1||Talaromyces eburneus:1||Tedizolid:1||Teicoplanin:1||Tigecycline:1||Toxin A/B:1||Trough:1||True infection:1||Tuberculous pericarditis:1||Turnaround time:1||Type ii:1||Undrainable:1||Unliquefied:1||Urinary tract infection:1||Uropathogen:1||VRE:1||VanA:1||VanB:1||VanDvanA:1||Vancomycin:1||VentilatorAssociated:1||Viral culture:1||Viridans group streptococcus:1||Viridans streptococci:1||Virus:1||Whole blood:1||Whole exome sequencing:1||Wholegenome sequencing:1||Xpert MTB/RIF assay:1||Yokenella regensburgei:1||acidfast bacilli:1||allogeneic hematopoietic cell transplantation:1||antibiotic prophylaxis:1||antibiotic resistance:1||attributable mortality:1||bedaquiline:1||blood transfusion:1||bloodstream infection:1||bronchoscopy:1||casecontrol studies:1||casecontrol study:1||cefepime:1||central nervous system:1||central pair:1||cerebrospinal fluid:1||children:1||cholangiocarcinoma:1||ciprofloxacin resistance:1||clonorchis sinensis:1||coinfection:1||colitis:1||communityacquired i:1||communityonset:1||critical concentration:1||cytomegalovirus:1||decision support system:1||delamanid:1||diagnosis:1||discordant antimicrobial therapy:1||disputed mutations:1||electrophoresis:1||emm55 protein:1||empirical therapy:1||enterococci:1||epidemiology:1||evolution:1||exotoxins:1||extendedspectrum betalactamase (ESBL):1||extendedspectrum betalactamases (ESBLs):1||febrile neutropenia:1||fluconazole:1||fluconazole resistance:1||fluoroquinolones:1||fosfomycin:1||fungus:1||gallstone:1||gel:1||genotype 2:1||gramnegative bacteria:1||group A streptococci:1||gyrase mutation:1||healthcareassociated infection:1||hematopoietic stem cell transplant:1||human adenovirus:1||identification:1||immunoassay:1||inappropriate therapy:1||infection:1||intermittent therapy:1||isoniazid:1||leukemia:1||line probe assay:1||linezolid:1||lung diseases:1||macrolide:1||matched cohort study:1||methicillin resistance:1||microsatellite typing:1||motile cilia:1||multidrugresistance:1||multipl:1||multiplex realtime PCR:1||nodule:1||nonalbicans Candida:1||nontuberculous mycobacterium:1||norovirus:1||nosocomial infection:1||novel species:1||ofloxacin:1||optrA:1||outcome:1||parainfluenza virus:1||pediatr:1||pediatric cancer:1||performance:1||peritonitis:1||pleural effusion:1||pleural empyema:1||pneumococcus:1||polymerase chain reaction:1||primary ciliary dyskinesia:1||procalcitonin:1||protothecosis:1||pulsedfield:1||pyelonephritis:1||radial spokes:1||recurrence:1||recurrent upper and lower respiratory tract infections:1||refractory:1||rifabutin:1||rifampin resistance:1||rifamycins:1||rinse fluid:1||risk factor:1||rotavirus:1||rpoB:1||sensitivity and specificity:1||sepsis:1||sexually transmitted disease:1||sputum microbiology:1||steroids:1||streptococcus pyogenes:1||surgi:1||teicoplanin:1||trailing growth:1||tuberculoma:1||tuberculosis:1||urinary antigen test:1||urinary tract infection:1||urinary tract infections:1||validation:1||vancomycinresistant enterococci:1||viral infection:1||16S r:1||virus type:1||16S rRNA gene:1||16S rRNA sequence analysis:1||23S rRNA:1||23S ribosomal RNA:1||AFIASNoro:1||AFIASRota:1||AUC/MIC:1||Abscess:1||Absolute concentration method:1||Acinetobacter species:1||Actinotignum schaalii:1||Acute pyelonephritis:1||Adult:1||Adults:1||AdvanSure:1||AdvanSure MDRTB GenoBlot assay:1||Agreement:1||Algorithm:1||AmpC betalactamase:1||AmpliSens Pneumocystis jirovecii (carinii)FRT PCR:1||Anaerobic bacteria:1||Antiinfective agents:1||Antibacterial agents:1||Antibacterial susceptibility:1||Antibiotic resistance:1||Antifungal resistance:1||Antimicrobial resistance:1||Antimicrobial stewardship:1||ArmA:1||Atelectasis:1||BCG:1||BacT/AlerT 3D system:1||Bacillus:1||Bacterial:1||Bacterial multiplex polymerase chain reaction:1||Bacterial respiratory pathogen:1||Bacteroides pyogenes:1||Bartonella quintana:1||Bergeyella:1||BinaxNOW:1||Bladder cancer:1||Blood culture:1||Blood stream infection:1||Brevibacterium casei bacteremia:1||Burkholderia pseudomallei:1||C:1||CTX M:1||CTXM15:1||Candida albicans:1||Candida glabrata:1||Candida tropicalis:1||CarbapenemSaving:1||Catheterassociated contamination:1||Catheterrelated infection:1||Ceftriaxone:1||Centrifugation:1||Cephalosporin:1||Child:1||Chronic diseases:1||Ciprofloxacin:1||Clinical outcome:1||Clofazimine:1||Clonorchis sinensis:1||Clostridioides difficile:1||Clostridium:1||Coagulasenegative staphylococcus:1||Colonization:1||Com:1||Combination antibiotic regimens:1||CommunityAcquired Infections:1||Communityacquired:1||Communityonset pneumonia:1||Contaminant:1||Corynebacterineae:1||DNA sequencing:1||DNA target sequencing:1||Definitive antimicrobial therapy:1||Detection:1||Diabetic foot:1||Diagnostic yield:1||Dialister pneumosintes:1||Dimorphic fungus:1||Direct sequencing:1||Disseminated gonococcal infection:1||Disseminated infection:1||Dna gyrase:1||Dna topoisomerases:1||Drainage:1||Drug susceptibility testing:1||E. coli:1||E. coli O63:H6:1||EHEC:1||Endobronchial ultrasoundguided transbronchial needle aspiration (EBUSTBNA):1||Enterobacter:1||Enterobacter cloacae complex:1||Enterococcus faecium:1||EpsteinBarr virus:1||Erysipelothrix rhusiopathiae:1||Etiology:1||Exophiala:1||Extendedspectrum βlactamase:1||Extensively drugresistant tuberculosis:1||FAN Plus blood culture bottle:1||Febrile neutropenia:1||Filamentous fungi:1||FilmArray Pneumonia Panel plus:1||

STATISTICS: Total View :5,214,431; Today View :1,125

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE